Polycystic Ovary Syndrome and Liraglutide

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

April 30, 2013

Conditions
PCOSObesity
Interventions
DRUG

liraglutide

DRUG

metformin

Trial Locations (1)

1000

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT01899430 - Polycystic Ovary Syndrome and Liraglutide | Biotech Hunter | Biotech Hunter